168 related articles for article (PubMed ID: 21428906)
1. Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma.
Oh CK; Raible D; Geba GP; Molfino NA
Inflamm Allergy Drug Targets; 2011 Jun; 10(3):180-6. PubMed ID: 21428906
[TBL] [Abstract][Full Text] [Related]
2. MEDI-528, an anti-IL-9 humanized antibody for the treatment of asthma.
Antoniu SA
Curr Opin Mol Ther; 2010 Apr; 12(2):233-9. PubMed ID: 20373267
[TBL] [Abstract][Full Text] [Related]
3. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma.
Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP
Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909
[TBL] [Abstract][Full Text] [Related]
4. Cytokine regulation of mucus production in a model of allergic asthma.
Cohn L; Whittaker L; Niu N; Homer RJ
Novartis Found Symp; 2002; 248():201-13; discussion 213-20, 277-82. PubMed ID: 12568496
[TBL] [Abstract][Full Text] [Related]
5. [The role of interleukin-18 in the pathogenesis of bronchial asthma and other allergic diseases and in activation of basophils and mastocytes].
Kamiński M; Kłoda K; Pawlik A
Pneumonol Alergol Pol; 2008; 76(6):432-6. PubMed ID: 19173192
[TBL] [Abstract][Full Text] [Related]
6. Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers.
White B; Leon F; White W; Robbie G
Clin Ther; 2009 Apr; 31(4):728-40. PubMed ID: 19446146
[TBL] [Abstract][Full Text] [Related]
7. Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse.
van Rijt LS; Lambrecht BN
Microsc Res Tech; 2001 May; 53(4):256-72. PubMed ID: 11340671
[TBL] [Abstract][Full Text] [Related]
8. Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.
Ishikawa Y; Yoshimoto T; Nakanishi K
Int Immunol; 2006 Jun; 18(6):847-55. PubMed ID: 16611648
[TBL] [Abstract][Full Text] [Related]
9. Effects of anticytokine therapy in a mouse model of chronic asthma.
Kumar RK; Herbert C; Webb DC; Li L; Foster PS
Am J Respir Crit Care Med; 2004 Nov; 170(10):1043-8. PubMed ID: 15306533
[TBL] [Abstract][Full Text] [Related]
10. Experimental approaches towards allergic asthma therapy-murine asthma models.
Wegmann M; Hauber HP
Recent Pat Inflamm Allergy Drug Discov; 2010 Jan; 4(1):37-53. PubMed ID: 19891606
[TBL] [Abstract][Full Text] [Related]
11. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle?
Robinson DS
J Allergy Clin Immunol; 2004 Jul; 114(1):58-65. PubMed ID: 15241345
[TBL] [Abstract][Full Text] [Related]
12. Th2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthma.
Zhou Y; McLane M; Levitt RC
Respir Res; 2001; 2(2):80-4. PubMed ID: 11686869
[TBL] [Abstract][Full Text] [Related]
13. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model.
Cheng G; Arima M; Honda K; Hirata H; Eda F; Yoshida N; Fukushima F; Ishii Y; Fukuda T
Am J Respir Crit Care Med; 2002 Aug; 166(3):409-16. PubMed ID: 12153980
[TBL] [Abstract][Full Text] [Related]
14. IgE-dependent mast cell activation potentiates airway responses in murine asthma models.
Mayr SI; Zuberi RI; Zhang M; de Sousa-Hitzler J; Ngo K; Kuwabara Y; Yu L; Fung-Leung WP; Liu FT
J Immunol; 2002 Aug; 169(4):2061-8. PubMed ID: 12165533
[TBL] [Abstract][Full Text] [Related]
15. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylactogenic anti-IgE antibody.
Coyle AJ; Wagner K; Bertrand C; Tsuyuki S; Bews J; Heusser C
J Exp Med; 1996 Apr; 183(4):1303-10. PubMed ID: 8666888
[TBL] [Abstract][Full Text] [Related]
16. Antibody therapy for the management of severe asthma with eosinophilic inflammation.
Ohta K; Nagase H; Suzukawa M; Ohta S
Int Immunol; 2017 Jul; 29(7):337-343. PubMed ID: 28910970
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
Brightling CE; Symon FA; Holgate ST; Wardlaw AJ; Pavord ID; Bradding P
Clin Exp Allergy; 2003 Dec; 33(12):1711-6. PubMed ID: 14656359
[TBL] [Abstract][Full Text] [Related]
18. The role of the mast cell in asthma: a reassessment.
Bradding P
Curr Opin Allergy Clin Immunol; 2003 Feb; 3(1):45-50. PubMed ID: 12582314
[TBL] [Abstract][Full Text] [Related]
19. Mepolizumab for eosinophilic severe asthma: recent studies.
Robinson DS; Kariyawasam HH
Expert Opin Biol Ther; 2015 Jun; 15(6):909-14. PubMed ID: 25951938
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-9 as a possible therapeutic target in both asthma and chronic obstructive airways disease.
McNamara PS; Smyth RL
Drug News Perspect; 2005 Dec; 18(10):615-21. PubMed ID: 16491163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
